Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study

BackgroundThe BETACONNECT autoinjector and myBETAapp app were designed to support patients with multiple sclerosis receiving interferon β-1b and are an ideal platform for digital observational studies. A recent pilot study in Germany demonstrated the feasibility of using the...

Full description

Bibliographic Details
Main Authors: Volker Limmroth, Kirsten Bayer-Gersmann, Christian Mueller, Markus Schürks
Format: Article
Language:English
Published: JMIR Publications 2022-03-01
Series:JMIR Formative Research
Online Access:https://formative.jmir.org/2022/3/e31972